课题基金 / 基金详情

STRUCTURE OF IMPORTIN B BOUND TO THE ADAPTOR SNURPORTIN

STRUCTURE OF IMPORTIN B BOUND TO THE ADAPTOR SNURPORTIN
与适配器 SNURPORTIN 结合的导入蛋白 B 的结构
批准号:
7955543
负责人:
Gino Cingolani
金额:
$11.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2010-06-30

项目摘要

项目成果

Gino Cingolani的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 Importin b是最具特性的核输入受体,它将胞质蛋白输入到细胞核中。大多数细胞质输入底物是由Importin b与接头Importin a形成的复合体输入的,在这个反应中需要GTP被小的GTP酶Ran水解。 SnRNP代表通过与特定适配器Snurportin形成的复合体中的Importin B而被导入到核中的进口货物的专门子集。我们已经生化定位了SNurportin(SIBB)中最小的Importin b结合区,它跨越了蛋白质的1-68区,并获得了人Importin b(876个残基)与sIBB(Res 1-68)结合的晶体。这些晶体是在高硫酸铵下和~1.8A的X射线衍射下获得的。在结构中,只有sIBB的25-68区域的电子密度可见,该电子密度通过疏水相互作用(可能由高硫酸铵稳定)与Importin b结合。相比之下,sIBB的1-24区域也对高亲和力结合很重要,在我们的晶体中看不到,这可能是由于结晶溶液(~1.5M硫酸铵)的高离子强度。 在尝试可视化整个sIBB-域(RES.1-68),我们得到了生理离子强度(~175 mM)的Importin b:SIBB晶体。室内初步的衍射分析表明,这些晶体也能将X射线衍射到高分辨率。 这个快速访问方案的目标是获得A1(或F1)的束流时间,并从我们的新晶体形式中进行完整的数据收集。考虑到晶体的晶胞大小、空间群(P212121)和高的衍射质量,完整的数据集通常可以在2-3小时内测量到。如果我们有24小时的光束时间,我们可以从5-6个晶体中收集完整的X射线数据。原则上,即使是12个小时也足够了。因此,请求的波束时间最短(12-24小时)。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Importin b is the best characterized nuclear import receptor, which import cytoplasmic protein into the cell nucleus. The majority of cytoplasmic import substrates are imported by importin b in complex with the adaptor importin a, in a reaction which requires GTP hydrolysis by the small GTPase Ran. snRNP represents a specialized subset of import cargos that are imported into the nucleus by importin b in complex with the specific adaptor snurportin. We have biochemical mapped the minimum Importin b-Binding domain in Snurportin (sIBB), which spans region 1-68 of the protein, and obtained crystals of human importin b (876 residues) bound to the sIBB(res 1-68). These crystals were obtained under high ammonium sulphate and diffract X-rays to ~1.8A. In the structure only region 25-68 of the sIBB is visible in the electron density, which is bound to importin b via hydrophobic interactions (likely stabilized by the high ammonium sulphate). In contrast region 1-24 of the sIBB, also important for high affinity binding, is not visible in our crystal, likely due to the high ionic strength of the crystallization solution (~1.5M Ammonium Sulphate). In the attempt to visualize the entire sIBB-domain (res. 1-68), we have obtained crystals of importin b:sIBB at physiological ionic strength (~175mM NaCl). Preliminary diffraction analysis in house indicates these crystals also diffract X-rays to high resolution. The goal of this quick access proposal is to obtain beam-time at A1 (or F1) and carry out a complete data collection from our new crystal form. Given the unit cell size, space group (P212121) and the high diffraction quality of the crystals in hand, complete data set can be measured usually within 2-3 hours. If we had 24 hours of beamtime we could collect complete x-ray data from 5-6 crystals. Even 12-hours would be - in principle- sufficient. So the beam-time requested is minimal (12-24 hours).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Protein therapeutics inspired by importins
  • 批准号:
    10506677
  • 项目类别:
  • 资助金额:
    $42.9万
  • 财政年份:
    2022
  • 负责人:
    Gino Cingolani
  • 依托单位:
Mechanism of Viral Genome Delivery into Cells
  • 批准号:
    10727074
  • 项目类别:
  • 资助金额:
    $2.84万
  • 财政年份:
    2021
  • 负责人:
    Gino Cingolani
  • 依托单位:
Mechanism of Viral Genome Delivery into Cells
  • 批准号:
    10413047
  • 项目类别:
  • 资助金额:
    $57.66万
  • 财政年份:
    2021
  • 负责人:
    Gino Cingolani
  • 依托单位:
Mechanism of Viral Genome Delivery into Cells
  • 批准号:
    10633050
  • 项目类别:
  • 资助金额:
    $5.67万
  • 财政年份:
    2021
  • 负责人:
    Gino Cingolani
  • 依托单位:
海外基金